0001209191-19-014057.txt : 20190227
0001209191-19-014057.hdr.sgml : 20190227
20190227162233
ACCESSION NUMBER: 0001209191-19-014057
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190225
FILED AS OF DATE: 20190227
DATE AS OF CHANGE: 20190227
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ward Keith Wayne
CENTRAL INDEX KEY: 0001662394
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37785
FILM NUMBER: 19638020
MAIL ADDRESS:
STREET 1: C/O REATA PHARMACEUTICALS, INC.
STREET 2: 2801 GATEWAY DR. SUITE 150
CITY: IRVING
STATE: TX
ZIP: 75063
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REATA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001358762
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 113651945
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2801 GATEWAY DRIVE SUITE 150
CITY: IRVING
STATE: TX
ZIP: 75063
BUSINESS PHONE: 972-865-2206
MAIL ADDRESS:
STREET 1: 2801 GATEWAY DRIVE SUITE 150
CITY: IRVING
STATE: TX
ZIP: 75063
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-02-25
0
0001358762
REATA PHARMACEUTICALS INC
RETA
0001662394
Ward Keith Wayne
2801 GATEWAY DRIVE
SUITE 150
IRVING
TX
75063
0
1
0
0
Chief Development Officer
Class A common stock
2019-02-25
4
C
0
15183
A
23803
D
Class A common stock
2019-02-25
4
S
0
15183
91.00
D
8620
D
Class A common stock
2019-02-26
4
C
0
25184
A
33804
D
Class A common stock
2019-02-26
4
S
0
16817
91.00
D
16987
D
Class A common stock
2019-02-26
4
S
0
8367
91.62
D
8620
D
Employee Stock Option (right to buy)
11.00
2019-02-25
4
M
0
15183
0.00
D
2026-05-25
Class B common stock
15183
92967
D
Class B common stock
2019-02-25
4
M
0
15183
11.00
A
Class A common stock
15183
15183
D
Class B common stock
2019-02-25
4
C
0
15183
D
Class A common stock
15183
0
D
Employee Stock Option (right to buy)
11.00
2019-02-26
4
M
0
16817
0.00
D
2026-05-25
Class B common stock
16817
76150
D
Employee Stock Option (right to buy)
11.62
2019-02-26
4
M
0
8367
0.00
D
2023-06-15
Class B common stock
8367
0
D
Class B common stock
2019-02-26
4
M
0
16817
11.00
A
Class A common stock
16817
16817
D
Class B common stock
2019-02-26
4
M
0
8367
11.62
A
Class A common stock
8367
25184
D
Class B common stock
2019-02-26
4
C
0
25184
D
Class A common stock
25184
0
D
The exercise, conversion and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 27, 2018.
The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date.
The options, representing a right to purchase a total of 108,150 shares, vest in sixteen equal quarterly installments beginning on August 25, 2016.
The options, representing a right to purchase a total of 82,287 shares, vested in twenty equal quarterly installments beginning on September 15, 2013.
/s/ Michael D. Wortley, attorney-in-fact
2019-02-27